Related Experiment Video
Updated: Jul 13, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
N-Acetylcysteine in the prevention of ototoxicity
1Charité Campus Benjamin Franklin, Medizinische Klinik IV, Nephrologie, Berlin, Germany. Martin.Tepel@charite.de
Abstract:
Prevention of ototoxicity after the administration of aminoglycoside antibiotics has been notably difficult, in particular in patients with chronic kidney disease. Feldman et al. report that oral administration of 600 mg N-acetylcysteine twice daily significantly ameliorates gentamicin-induced ototoxicity in hemodialysis patients. That approach may help to prevent aminoglycoside-induced hearing loss in these high-risk patients in daily practice.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Prevention of Further Absorption of Poison
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...